Monash initiatives in dementia and Alzheimer's research

Various initiatives at Monash University are advancing the understanding, diagnosis, and treatment of dementia and Alzheimer's disease:

Dr. Amandeep Kaur from the Monash Institute of Pharmaceutical Sciences developed a method using fluorescent sensors for early detection of neurodegenerative diseases.
Matthew Pase's research highlights the protective role of good sleep against dementia.
An international team, including Monash University's School of Psychological Sciences, developed a test predicting dementia up to nine years before diagnosis.
Professor Lei Zhang's study on gut microbiota's role in cognitive health suggests lifestyle changes to reverse cognitive decline.
Research by Associate Professor Chris Moran and Professor Velandai Srikanth links mid-life visceral fat to brain ageing and dementia risk.
The Centre of Research Excellence in Enhanced Dementia Diagnosis (CREEDD) conducted qualitative research to improve dementia diagnosis pathways.
A phase 2b clinical trial led by Professor Terence O’Brien and Dr. Lucy Vivash is assessing sodium selenate for treating behavioural variant frontotemporal dementia.
Research into terminal lucidity by the Faculty of Medicine, Nursing and Health Sciences explores end-of-life care for dementia patients.
Associate Professor Michele Callisaya advocates for gait measurement as a 'sixth vital sign' to prevent falls in dementia patients.